EU explores legal avenues amid AstraZeneca vaccine dispute
BRUSSELS (AP) — Amid a dispute over expected shortfalls, the European Union is looking at legal ways to guarantee the delivery of all the COVID-19 vaccine doses it bought from AstraZeneca and other drugmakers as regulators are set to consider approving the Anglo-Swedish company's vaccine for use in the 27-nation EU.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
